160 related articles for article (PubMed ID: 20022897)
1. How necessary is a fast testkit for mitigation of pandemic flu?
Chin J; Koh G; Lee DY
J R Soc Interface; 2010 Jul; 7(48):1033-47. PubMed ID: 20022897
[TBL] [Abstract][Full Text] [Related]
2. Pandemic influenza: overview of vaccines and antiviral drugs.
Cox MM
Yale J Biol Med; 2005 Oct; 78(5):321-8. PubMed ID: 17132338
[TBL] [Abstract][Full Text] [Related]
3. Effective, robust design of community mitigation for pandemic influenza: a systematic examination of proposed US guidance.
Davey VJ; Glass RJ; Min HJ; Beyeler WE; Glass LM
PLoS One; 2008 Jul; 3(7):e2606. PubMed ID: 18596963
[TBL] [Abstract][Full Text] [Related]
4. Containing pandemic influenza at the source.
Longini IM; Nizam A; Xu S; Ungchusak K; Hanshaoworakul W; Cummings DA; Halloran ME
Science; 2005 Aug; 309(5737):1083-7. PubMed ID: 16079251
[TBL] [Abstract][Full Text] [Related]
5. Containing pandemic influenza with antiviral agents.
Longini IM; Halloran ME; Nizam A; Yang Y
Am J Epidemiol; 2004 Apr; 159(7):623-33. PubMed ID: 15033640
[TBL] [Abstract][Full Text] [Related]
6. Antiviral resistance and the control of pandemic influenza.
Lipsitch M; Cohen T; Murray M; Levin BR
PLoS Med; 2007 Jan; 4(1):e15. PubMed ID: 17253900
[TBL] [Abstract][Full Text] [Related]
7. [The use of antiviral agents during an (impending) influenza pandemic].
Opstelten W; van Steenbergen JE; van Essen GA; Van der Sande MA
Ned Tijdschr Geneeskd; 2007 May; 151(18):1008-12. PubMed ID: 17508684
[TBL] [Abstract][Full Text] [Related]
8. Mitigation of pandemic influenza: review of cost-effectiveness studies.
Lugnér AK; Postma MJ
Expert Rev Pharmacoecon Outcomes Res; 2009 Dec; 9(6):547-58. PubMed ID: 19941432
[TBL] [Abstract][Full Text] [Related]
9. Mitigation strategies for pandemic influenza in the United States.
Germann TC; Kadau K; Longini IM; Macken CA
Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5935-40. PubMed ID: 16585506
[TBL] [Abstract][Full Text] [Related]
10. [Role of antiviral drugs in containing pandemic influenza. Contribution of recent modelling exercises synthesis prepared by the InVS/Inserm "epidemiology" group - November 2005].
Lévy-Bruhl D
Med Mal Infect; 2006 Sep; 36(9):449-53. PubMed ID: 17027218
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic.
Khazeni N; Hutton DW; Garber AM; Owens DK
Ann Intern Med; 2009 Dec; 151(12):840-53. PubMed ID: 20008760
[TBL] [Abstract][Full Text] [Related]
12. Influenza pandemic intervention planning using InfluSim: pharmaceutical and non- pharmaceutical interventions.
Duerr HP; Brockmann SO; Piechotowski I; Schwehm M; Eichner M
BMC Infect Dis; 2007 Jul; 7():76. PubMed ID: 17629919
[TBL] [Abstract][Full Text] [Related]
13. Modelling strategic use of the national antiviral stockpile during the CONTAIN and SUSTAIN phases of an Australian pandemic influenza response.
McVernon J; McCaw JM; Nolan TM
Aust N Z J Public Health; 2010 Apr; 34(2):113-9. PubMed ID: 23331352
[TBL] [Abstract][Full Text] [Related]
14. Strategies for mitigating an influenza pandemic.
Ferguson NM; Cummings DA; Fraser C; Cajka JC; Cooley PC; Burke DS
Nature; 2006 Jul; 442(7101):448-52. PubMed ID: 16642006
[TBL] [Abstract][Full Text] [Related]
15. Are we prepared for the next influenza pandemic? Lessons from modelling different preparedness policies against four pandemic scenarios.
Panovska-Griffiths J; Grieco L; van Leeuwen E; Baguelin M; Pebody R; Utley M
J Theor Biol; 2019 Nov; 481():223-232. PubMed ID: 31059716
[TBL] [Abstract][Full Text] [Related]
16. Antiviral resistance during pandemic influenza: implications for stockpiling and drug use.
Arino J; Bowman CS; Moghadas SM
BMC Infect Dis; 2009 Jan; 9():8. PubMed ID: 19161634
[TBL] [Abstract][Full Text] [Related]
17. Assessing the role of basic control measures, antivirals and vaccine in curtailing pandemic influenza: scenarios for the US, UK and the Netherlands.
Nuño M; Chowell G; Gumel AB
J R Soc Interface; 2007 Jun; 4(14):505-21. PubMed ID: 17251132
[TBL] [Abstract][Full Text] [Related]
18. Optimal control for pandemic influenza: the role of limited antiviral treatment and isolation.
Lee S; Chowell G; Castillo-Chávez C
J Theor Biol; 2010 Jul; 265(2):136-50. PubMed ID: 20382168
[TBL] [Abstract][Full Text] [Related]
19. Vaccines and antiviral drugs in pandemic preparedness.
Monto AS
Emerg Infect Dis; 2006 Jan; 12(1):55-60. PubMed ID: 16494718
[TBL] [Abstract][Full Text] [Related]
20. Experience with oseltamivir in the control of a nursing home influenza B outbreak.
Parker R; Loewen N; Skowronski D
Can Commun Dis Rep; 2001 Mar; 27(5):37-40. PubMed ID: 11260987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
